Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

This study has been completed.
Information provided by (Responsible Party):
Fate Therapeutics Identifier:
First received: February 1, 2012
Last updated: September 9, 2016
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)